BRCA1 and prostate carcinoma: Notably, mutations in BRCA1 have been implicated in risk of hereditary cancers, such as breast, ovarian, pancreatic, and prostate cancer [45], whereas reduced levels of BRCA1 mRNA and protein have also been associated with sporadic tumours [46], [47], [48].